IP Library Granted Patent US 8,192,960
Granted Patent B2
US 8,192,960 · App. 11/101,977 · Granted Jun 5, 2012

One component and two component DNA Pol III replicases and uses thereof

Assignee: Qiagen North American Holdings
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,192,960
App. No.
11/101,977
Granted
Jun 5, 2012
Kind
B2
Abstract

The invention provides one-component and two-component DNA polymerases, as well as kits comprising the same, and methods of using the same for nucleic amplification and nucleic acid sequencing.

Claims (21)

1. A method for replicating a DNA molecule, comprising subjecting a DNA molecule to a replication reaction in a replication reaction mixture, which replication reaction mixture comprises a minimal functional Pol III replicase, wherein said minimal functional Pol III replicase comprises a first component, which first component comprises an α subunit from a gram negative bacteria, wherein said α subunit comprises amino acid consensus sequence motifs A, B, and C arranged in the order C-A-B from amino terminus to carboxyl terminus, wherein said minimal functional Pol III replicase and said replication reaction mixture lack each subunit (τ/γ, δ and δ′) of the clamp loader, and wherein said DNA molecule is replicated in said replication reaction in said replication reaction mixture by said minimal functional Pol III at a rate of at least 100 nucleotides per second.

2. The method according to claim 1 , wherein said minimal functional Pol III replicase is a thermostable minimal Pol III.

3. The method according to claim 1 , wherein said gram negative bacteria is selected from the group consisting of the genera Thermus, Aquifex , and Thermatoga.

4. The method according to claim 1 , wherein said DNA is double stranded DNA.

5. The method according to claim 1 , wherein said first component further comprises an ε subunit

6. The method according to claim 1 , wherein said minimal functional Pol III replicase is a single component Pol III replicase.

7. The method according to claim 1 , wherein said minimal functional Pol III replicase is a two component Pol III replicase further comprising a second component, which second component comprises a processivity clamp.

8. The method according to claim 1 , wherein said method is an amplification method, wherein said replication reaction is an amplification reaction, and said replication reaction mixture is an amplification reaction mixture.

9. The method according to claim 8 , wherein said amplification method is a PCR method, wherein said amplification reaction is a polymerase chain reaction, and wherein said amplification reaction mixture is a PCR mixture.

10. The method according to claim 1 , wherein said method is a sequencing method, wherein said replication reaction is a sequencing reaction, wherein said replication reaction mixture is a sequencing reaction mixture.

11. The method according to claim 1 , wherein said replication reaction mixture lacks CaCl2.

12. The method according to claim 1 , wherein said replication reaction mixture is a zwitterionic buffer comprising a weak organic acid and a weak organic base.

13. The method according to claim 1 , wherein said replication reaction mixture has a pH of between about pH7.5-8.9.

14. The method according to claim 1 , wherein said a subunit is present in said replication reaction mixture at a concentration of not less than 6 ng/μL.

15. The method according to claim 1 , wherein said a subunit is a DnaE a subunit from a gram negative bacteria and the spacing between said motif C and said motif A ranges from about 153 to about 155 amino acids, and wherein the spacing between said motif A and said motif B ranges from about 195 to about 201 amino acids.

16. The method according to claim 15 , wherein said motif A comprises the sequence set forth in SEQ ID NO:15.

17. The method according to claim 15 , wherein said motif B comprises the sequence set forth in SEQ ID NO:16.

18. The method according to claim 15 , wherein said motif C comprises the sequence set forth in SEQ ID NO:17.

19. The method according to claim 15 , wherein said motif A comprises the sequence set forth in SEQ ID NO:21.

20. The method according to claim 15 , wherein said motif B comprises the sequence set forth in SEQ ID NO:22.

21. The method according to claim 15 , wherein said motif C comprises the sequence set forth in SEQ ID NO:23.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2009
From: PETERS, LARS-ERIK
To: QIAGEN NORTH AMERICAN HOLDINGS, INC.
Reel/Frame 022904/0707 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2007
From: EPPENDORF AG
To: QIAGEN NORTH AMERICAN HOLDINGS, INC.
Reel/Frame 018923/0314 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2005
From: PETERS, LARS-ERIK; ETTINGER, ANNA
To: EPPENDORF AG
Reel/Frame 016495/0690 →
Continuity (3)
Provisional Application 60560793 · Apr 7, 2004
Provisional Application 60641183 · Jan 3, 2005
Related Publication 20060211003A1 · Sep 21, 2006